UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934

 

Date of Report (Date of earliest event reported):  May 3, 2016

 

 

BRISTOL-MYERS SQUIBB COMPANY

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

 

1-1136

 

22-0790350

(State or Other
Jurisdiction of
Incorporation)

 

(Commission File
Number)

 

(IRS Employer
Identification
Number)

 

345 Park Avenue

New York, NY 10154

(Address of Principal Executive Office)

 

Registrant’s telephone number, including area code: (212) 546-4000

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o               Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o               Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o               Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o               Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

(a) The Annual Meeting of the Company was held on May 3, 2016.

 

(b) Shareholders voted on the matters set forth below.

 

Item 1. The shareholders elected each of the Company’s 11 nominees to serve as directors of the Company until the 2017 Annual Meeting based upon the following votes:

 

 

 

 

 

 

 

 

 

Broker

 

 

For

 

Against

 

Abstain

 

Non-Vote

 

 

 

 

 

 

 

 

 

Lamberto Andreotti

 

1,220,457,771

 

13,003,922

 

2,750,337

 

254,917,592

Peter J. Arduini

 

1,213,484,038

 

19,679,382

 

3,048,610

 

254,917,592

Giovanni Caforio, M.D.

 

1,225,948,206

 

7,427,446

 

2,836,378

 

254,917,592

Laurie H. Glimcher, M.D.

 

1,222,538,959

 

10,484,694

 

3,188,377

 

254,917,592

Michael Grobstein

 

1,198,859,879

 

34,259,001

 

3,093,150

 

254,917,592

Alan J. Lacy

 

1,202,232,306

 

30,941,660

 

3,038,064

 

254,917,592

Thomas J. Lynch, Jr., M.D.

 

1,223,813,589

 

9,469,374

 

2,929,067

 

254,917,592

Dinesh C. Paliwal

 

1,204,102,684

 

28,989,088

 

3,120,258

 

254,917,592

Vicki L. Sato, Ph.D.

 

1,222,593,135

 

10,638,376

 

2,980,519

 

254,917,592

Gerald L. Storch

 

1,199,761,866

 

33,199,927

 

3,250,237

 

254,917,592

Togo D. West, Jr.

 

1,219,417,587

 

13,720,728

 

3,073,715

 

254,917,592

 

Item 2. The management proposal on the advisory vote to approve the compensation of our named executive officers was approved based upon the following votes:

 

 

 

 

Broker

For

Against

Abstain

Non-Vote

1,187,110,600

42,219,344

6,882,086

254,917,592

 

Item 3. The appointment of Deloitte & Touche LLP as independent registered public accounting firm for the Company for 2016 was ratified based upon the following votes:

 

For

Against

Abstain

 

1,426,088,842

61,099,466

3,941,314

 

 

Item 4.  The shareholder proposal on special shareowner meetings was rejected based upon the following votes:

 

 

 

 

Broker

For

Against

Abstain

Non-Vote

493,171,239

733,464,877

9,575,914

254,917,592

 



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

BRISTOL-MYERS SQUIBB COMPANY

 

 

Dated: May 6, 2016

By:

/s/ Katherine R. Kelly

 

 

 

Name:

Katherine R. Kelly

 

 

Title:

Associate General Counsel and

 

 

Corporate Secretary